Nicholls SJ - Search Results

1

Effect of two intensive statin regimens on progression of coronary disease.

Nicholls SJ, Ballantyne CM, Barter PJ, Chapman MJ, Erbel RM, Libby P, Raichlen JS, Uno K, Borgman M, Wolski K, Nissen SE. Nicholls SJ, et al. N Engl J Med. 2011 Dec 1;365(22):2078-87. doi: 10.1056/NEJMoa1110874. Epub 2011 Nov 15. N Engl J Med. 2011. PMID: 22085316 Free article. Clinical Trial.

2

Antiinflammatory properties of HDL.

Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM. Barter PJ, et al. Circ Res. 2004 Oct 15;95(8):764-72. doi: 10.1161/01.RES.0000146094.59640.13. Circ Res. 2004. PMID: 15486323 Review.

3

The role of myeloperoxidase in the pathogenesis of coronary artery disease.

Nicholls SJ, Hazen SL. Nicholls SJ, et al. Jpn J Infect Dis. 2004 Oct;57(5):S21-2. Jpn J Infect Dis. 2004. PMID: 15507760 Review.

4

Strategies to promote HDL-C: an emerging therapeutic target.

Nicholls SJ, Nissen SE. Nicholls SJ, et al. Eur Heart J. 2005 May;26(9):853-5. doi: 10.1093/eurheartj/ehi218. Epub 2005 Mar 11. Eur Heart J. 2005. PMID: 15764616 No abstract available.

5

High-density lipoproteins as therapeutic targets.

Nicholls SJ, Rye KA, Barter PJ. Nicholls SJ, et al. Curr Opin Lipidol. 2005 Jun;16(3):345-9. doi: 10.1097/01.mol.0000169356.58513.25. Curr Opin Lipidol. 2005. PMID: 15891397 Review.

6

Impact of short-term administration of high-density lipoproteins and atorvastatin on atherosclerosis in rabbits.

Nicholls SJ, Cutri B, Worthley SG, Kee P, Rye KA, Bao S, Barter PJ. Nicholls SJ, et al. Arterioscler Thromb Vasc Biol. 2005 Nov;25(11):2416-21. doi: 10.1161/01.ATV.0000184760.95957.d6. Epub 2005 Sep 1. Arterioscler Thromb Vasc Biol. 2005. PMID: 16141405

7

Effect of atorvastatin (80 mg/day) versus pravastatin (40 mg/day) on arterial remodeling at coronary branch points (from the REVERSAL study).

Nicholls SJ, Tuzcu EM, Schoenhagen P, Sipahi I, Crowe T, Kapadia S, Nissen SE. Nicholls SJ, et al. Am J Cardiol. 2005 Dec 15;96(12):1636-9. doi: 10.1016/j.amjcard.2005.07.085. Epub 2005 Oct 28. Am J Cardiol. 2005. PMID: 16360349

8

Paradoxical increase in lumen size during progression of coronary atherosclerosis: observations from the REVERSAL trial.

Sipahi I, Tuzcu EM, Schoenhagen P, Nicholls SJ, Chen MS, Crowe T, Loyd AB, Kapadia S, Nissen SE. Sipahi I, et al. Among authors: nicholls sj. Atherosclerosis. 2006 Nov;189(1):229-35. doi: 10.1016/j.atherosclerosis.2005.12.006. Epub 2006 Jan 20. Atherosclerosis. 2006. PMID: 16427643 Clinical Trial.

9

[Assessment of progression and regression of coronary atherosclerosis by intravascular ultrasound. A new paradigm shift?].

Nicholls SJ, Sipahi I, Tuzcu EM. Nicholls SJ, et al. Rev Esp Cardiol. 2006 Jan;59(1):57-66. Rev Esp Cardiol. 2006. PMID: 16434005 Free article. Review. Spanish.

10

Relationship between atheroma regression and change in lumen size after infusion of apolipoprotein A-I Milano.

Nicholls SJ, Tuzcu EM, Sipahi I, Schoenhagen P, Crowe T, Kapadia S, Nissen SE. Nicholls SJ, et al. J Am Coll Cardiol. 2006 Mar 7;47(5):992-7. doi: 10.1016/j.jacc.2005.11.040. Epub 2006 Feb 9. J Am Coll Cardiol. 2006. PMID: 16516083 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

606 results

Search Page